Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2011

01-08-2011 | Letter to the Editor

A case of subclinical Cushing syndrome due to primary pigmented nodular adrenocortical disease associated with adrenocortical adenoma

Authors: Masanori Yoshida, Hironobu Sasano, Toyone Kikumori, Tsuneo Imai, Yoshiko Murakami, Shigeo Nakamura, Koichiro Ogawa, Misaki Miyata, Miho Murakami, Yutaka Oiso

Published in: Endocrine | Issue 1/2011

Login to get access

Excerpt

To the Editor, …
Literature
1.
J.A. Carney, W.F.J. Young, Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 2, 6–21 (1992)CrossRef
2.
J. Bertherat, A. Horvath, L. Groussin, S. Grabar, S. Boikos, L. Cazabat, R. Libe, F. René-Corail, S. Stergiopoulos, I. Bourdeau, T. Bei, E. Clauser, A. Calender, L.S. Kirschner, X. Bertagna, J.A. Carney, C.A. Stratakis, Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J. Clin. Endocrinol. Metab. 94, 2085–2091 (2009)PubMedCrossRef
3.
G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–5602 (2003)PubMedCrossRef
4.
H. Sasano, S. Miyazaki, T. Sawai, N. Sasano, H. Nagura, H. Funahashi, M. Aiba, H. Demura, Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. Mod. Pathol. 5, 23–29 (1992)PubMed
5.
S. Midorikawa, H. Sanada, S. Hashimoto, T. Suzuki, T. Watanabe, H. Sasano, Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes. Endocr. J. 48, 167–174 (2001)PubMedCrossRef
Metadata
Title
A case of subclinical Cushing syndrome due to primary pigmented nodular adrenocortical disease associated with adrenocortical adenoma
Authors
Masanori Yoshida
Hironobu Sasano
Toyone Kikumori
Tsuneo Imai
Yoshiko Murakami
Shigeo Nakamura
Koichiro Ogawa
Misaki Miyata
Miho Murakami
Yutaka Oiso
Publication date
01-08-2011
Publisher
Springer US
Published in
Endocrine / Issue 1/2011
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9457-2

Other articles of this Issue 1/2011

Endocrine 1/2011 Go to the issue

Original Article

The endothelial dysfunction in patients with type 2 diabetes mellitus is associated with IL-6 gene promoter polymorphism in Chinese population

Original Article

Desmopressin duration of antidiuretic action in patients with central diabetes insipidus

Original Article

Influence of diabetes mellitus on vertebral fractures in men with acromegaly

Original Article

Glucose regulates RMI1 expression through the E2F pathways in adipose cells

Original Article

The effect of selective oestrogen receptor antagonists in an in vitro model of growth plate chondrogenesis

Original Article

Health-related quality of life and fatigue in patients with adrenal incidentaloma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits